FDCDDQ
XENE icon

Federation des caisses Desjardins du Quebec’s Xenon Pharmaceuticals XENE Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40
Closed -$113 – 2226
2017
Q4 		$113 Hold
40
– – ﹤0.01% 2108
2017
Q3 		$118 Hold
40
– – ﹤0.01% 2059
2017
Q2 		$126 Sell
40
-10
-20% -$39 ﹤0.01% 2126
2017
Q1 		$200 Buy
+50
New +$393 ﹤0.01% 1747

Other funds holding XENE

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's XENE Position: Q1 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Xenon Pharmaceuticals (XENE) in Q1 2018, closing a stake of 40 shares — an estimated $113 sold.

Federation des caisses Desjardins du Quebec first reported a position in XENE in Q1 2017 and held it in 4 quarters. The position peaked at $200 in Q1 2017. 35 funds tracked by Wall St. Rank hold XENE as of Q1 2018.

  • Federation des caisses Desjardins du Quebec reported no remaining Xenon Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 40 Xenon Pharmaceuticals shares in Q1 2018, an estimated $113.
  • Federation des caisses Desjardins du Quebec first reported a position in Xenon Pharmaceuticals in Q1 2017 and held it in 4 quarters.
  • Federation des caisses Desjardins du Quebec's Xenon Pharmaceuticals position peaked at $200 in Q1 2017.
  • 35 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2018, filed 30 Aug 2024.